Adam Bonislawski - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Adam Bonislawski's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Adam Bonislawski

Adam Bonislawski

Verified

Freelance Journalist, Freelance

New York, United States

Final Covers

civil rights issues politicalimmigration

Doesn’t Cover

News, politics, green living, science, sports, and business.

Seniority Positions

Medium Formats

Content

Total articles 809

  • Final Rule Kaput, FDA Still Has Options for Exerting Authority Over Lab-Developed Tests

    By Adam Bonislawski Verified| 360Dx Verified NEW YORK – A US District Court's recent decision vacating the US Food and Drug Administration's (FDA's) final rule on laboratory-developed tests (LDTs) made clear that the agency does not have the legal authority to regulate these tests, settling, at least for the moment, a decades-long dispute between FDA and industry.

    By Adam Bonislawski Verified · 360Dx

    Apr. 15, 2025

  • Major Quanterix Investors Oppose Akoya Acquisition Deal, $30M Securities Purchase Agreement

    By Adam Bonislawski Verified| 360Dx Verified NEW YORK – Major shareholders of high-sensitivity immunoassay outfit Quanterix reiterated their opposition to the company's plan to acquire Akoya Biosciences following the announcement of a $30 million securities purchase agreement between the two firms. Investment firm Kent Lake issued a statement on Monday opposing a securities purchase agreement that Quanterix entered into with Akoya Biosciences on April 2, under which Akoya may sell Quanterix up to $30 million in convertible notes.

    By Adam Bonislawski Verified · 360Dx

    Apr. 08, 2025

  • Final Rule Kaput, FDA Still Has Options for Exerting Authority Over Lab-Developed Tests

    By Adam Bonislawski Verified| 360Dx Verified NEW YORK – A US District Court's recent decision vacating the US Food and Drug Administration's (FDA's) final rule on laboratory-developed tests (LDTs) made clear that the agency does not have the legal authority to regulate these tests, settling, at least for the moment, a decades-long dispute between FDA and industry.

    By Adam Bonislawski Verified · 360Dx

    Apr. 15, 2025

As seen in

Company Info

Freelance

Freelancer.com is the largest freelancing and crowdsourcing marketplace in the world, connecting over 81 million employers and freelancers across more than 247 countries. Founded in 2009 and based in Sydney, Australia, the platform allows employers to post jobs while freelancers can bid on these projects. It is publicly traded on the Australian Securities Exchange under the ticker ASX:FLN. The platform supports a variety of work categories, including software development, writing, design, and marketing. Freelancer.com also offers contests for creative work, where employers can award prize money to winning entries. Users can choose from different membership plans, including free and paid subscriptions, which provide various benefits. The mobile app enhances project management and communication for users on the go. With a diverse customer base that includes individuals, small businesses, and large enterprises, Freelancer.com plays a significant role in the global online economy.

De Pere, Wisconsin, United States